Blair William & Co. IL cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 15.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 172,705 shares of the pharmacy operator's stock after selling 30,798 shares during the quarter. Blair William & Co. IL's holdings in Walgreens Boots Alliance were worth $1,611,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. Intech Investment Management LLC purchased a new position in Walgreens Boots Alliance during the 3rd quarter worth $109,000. The Manufacturers Life Insurance Company grew its stake in shares of Walgreens Boots Alliance by 31.0% during the third quarter. The Manufacturers Life Insurance Company now owns 572,192 shares of the pharmacy operator's stock worth $5,127,000 after acquiring an additional 135,343 shares during the last quarter. FMR LLC increased its holdings in shares of Walgreens Boots Alliance by 2.5% during the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator's stock valued at $29,200,000 after acquiring an additional 80,525 shares in the last quarter. Bridgewater Associates LP purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at approximately $160,000. Finally, Glenmede Trust Co. NA boosted its stake in Walgreens Boots Alliance by 82.5% in the 3rd quarter. Glenmede Trust Co. NA now owns 40,268 shares of the pharmacy operator's stock worth $361,000 after purchasing an additional 18,199 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the stock. Royal Bank of Canada raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. StockNews.com began coverage on Walgreens Boots Alliance in a research note on Thursday. They issued a "hold" rating for the company. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $10.59.
View Our Latest Stock Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Performance
Walgreens Boots Alliance stock traded down $0.12 during mid-day trading on Thursday, hitting $11.06. The company had a trading volume of 22,718,139 shares, compared to its average volume of 20,802,564. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $9.56 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.62. The company's fifty day moving average is $10.79 and its 200-day moving average is $9.95. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $19.48.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm's revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the business earned $0.66 earnings per share. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
